Volume 17 - Issue 1 - January, 2009

Clinical & Industry News

Lack of Vitamin D Could Spell Heart Trouble

Researchers issue recommendations to screen for and treat Vitamin D deficiency

Vitamin D deficiency — traditionally associated with bone and muscle weakness — may also increase the risk of cardiovascular disease (CVD). A growing body of evidence links low 25-hydroxyvitamin D levels to common CVD risk factors such as hypertension, obesity and diabetes, as well as major cardiovascular events including st



Providence St. Vincent Medical Center Cath Lab

What is the size of your cath lab facility and number of staff members?

St. Vincent’s cath lab has seven rooms, one of which is a digital operating suite, shared with the cardiovascular operating room (CVOR). Of the remaining six rooms:

• one is a neuro/bi-plane room;
• three are dedicated to cardiac procedures;
• one is a Philips Allura Xper FD20 (Bothell, WA) used for peripheral cases, with the capability to also do cardiac procedures;
• one is used for both cardiac and peripheral procedures as a dual-plane room.

An outpatient cath lab affiliated with the hospit



Innovations in STEMI Interventions – Improvements in D2B Times through Medical Simulation

2010 Update: William Hamman claimed to be a physician, a claim that has since been proven false.

A report from the upcoming February 2009 LUMEN meeting

The STEMI process is comprised of three distinct processes — the pre-hospital EMS phase, the emergency department phase and the cardiac cath lab phase. Each phase has its own skilled people conducting their own specialized work. To increase STEMI procedure success and meet mandated door-to-balloon time guidelines, these processes must be streamlined and made more efficient through the creation of a standardized process and the following of approved protocols. Most STEMI procedures become chaotic as a lack of cohesive teamwork



Treatment of Complex Thrombotic Popliteal Chronic Total Occlusion

Using Pathway PV Jetstream or Laser Atherectomy, and Localized Delivery of Abciximab via ClearWay Rx Catheter

Part 4 in a 5-part series

In recent years, peripheral vascular intervention has seen significant growth with the advent of innovative devices, patient preferences for less invasive procedures and low morbidity associated with these procedures. Despite multiple new devices and approaches, thrombotic lesions and distal embolization remain a significant challenge for interventionalists. Thrombolysis has been utilized for many years as a primary modality for treatment



Optimizing Vascular Access Management — Focus on the Introducer Sheath and Entry Arteriotomy

Results of Pinnacle TIF Tip Sheath Safety and Feasibility Pilot Study

Introduction

Vascular access management (VAM) and its complications (VAC) remain a significant source of clinical and therefore economic costs in the interventional treatment of cardiovascular disease. Even with a trend towards a decreasing incidence of VAC in the last decade, VAC during percutaneous coronary interventions (PCI) have been reported between 0.4 – 27%, depending on the definition of complications.1-5 It is now clear that even with a “minor” complication, there are significant clini



A Holistic Approach to Cardiac Care – Integrative Cardiology Prevention, Early Detection, Treatment and Rehabilitation

Cardiovascular disease remains the leading cause of morbidity and mortality in the United States. According to the American Heart Association, every 30 seconds, an American dies of cardiovascular disease. The statistics for women are more staggering than that for men. What can we do to improve these statistics?

Scripps is well known for excellence in the treatment of cardiovascular disease. Scripps Center for Integrative Medicine offers sophisticated prevention, diagnostic testing and treatment programs that are personalized for each patient. This is a place where people come to find healin



Ask the Clinical Instructor

“Recently, there was a code in our lab. The anesthesiologist that responded kept checking for pupillary reactions. The cardiologist told him, ‘Nevermind, the patient received atropine.’ Why?”

— CIS Online Student, Tennessee

That would be partly right and partly wrong. To explain why, we need to revisit pharmacokinetics.

Last month, we explored vagal responses. In the article (available online in the December 2008 issue, at http://cathlabdigest.com/articles/Ask-Clinical-Instructor-A-QA-column-th...), the model of the “gas” and “brake” pe



The Movement to Outpatient Coronary Interventions

The movement of percutaneous coronary interventions (PCIs) from the inpatient to outpatient case type has become somewhat of a hot topic in recent months. We work with many hospital clients across the United States to analyze and understand their specific markets; to date, hospital volume data that details inpatient and outpatient procedures and market data in states that accurately report and track outpatient data does not yet support a widespread shift of PCI volumes from the inpatient to outpatient setting. Market data often lags, and in most states, outpatient data is not reliably and cons



The Ten-Minute Interview with… Karen Tarvid, RT(R)(CV)

I have worked as a traveling x-ray technologist for Cross Country TravCorps (Boca Raton, FL) since 1999. I have worked in Hawaii, California, Arizona, South Carolina, Nevada, Massachusetts, New Hampshire and Florida. I have specialized in the cath lab, electrophysiology procedures (EP) and special procedures (interventional radiology).

Why did you choose to work in the invasive cardiology field?
I chose this field because it is challenging, with opportunities to grow as a professional, as well as the wonderful feeling I get when I am able to help the physician and the amazing high



Conscious Sedation in the Cath Lab: Should we use what GI uses?

How much is enough conscious sedation (CS) for a cardiac catheterization procedure? Each lab likely has its own regimen. In our lab, most of our patients receive preprocedural oral valium (5mg) and Benadryl (25mg). In the lab, before the vascular access, we give versed (1-2mg) and fentanyl (25-50mcg) intravenously. Our patient is generally comfortable, sleepy, but can be aroused and conversant enough to tell us about pain or other problems. If the patient is agitated or highly anxious, we give additional doses of versed and fentanyl.

However, for GI and other procedures, the doses of CS d



  • « Previous
  •  | Page 1 of 2 | 
  • Next »